Dataset Information

Communication regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy".

ABSTRACT: When performing computational modeling and machine learning experiments, it is imperative to follow a protocol that minimizes bias. In this communication, we share our concerns regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy" published in this journal. We consider that the authors may have inadvertently biased their results by not guaranteeing complete independence of test samples from the training data. We corroborate our point by reproducing the experiment with the available data, showing that if full independence of the test set was ensured, the reported results should be lower. We ask the authors to provide more information regarding their article, as well as making available all code used to generate their results. Our experiments are available at https://doi.org/10.6084/m9.figshare.14124356.

SUBMITTER: Soares F

PROVIDER: S-EPMC9088369 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Communication regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy".

Soares Felipe F Yamashita Gabrielli G

Journal of Raman spectroscopy : JRS 20220321 7

When performing computational modeling and machine learning experiments, it is imperative to follow a protocol that minimizes bias. In this communication, we share our concerns regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy" published in this journal. We consider that the authors may have inadvertently biased their results by not guaranteeing complete independence of test samples from the training data. We corroborate our point by reproducing the exper ...[more]

PMID: 35572166

Similar Datasets

Project description:BackgroundShared decision making improves value-concordant decision-making around prostate cancer screening (PrCS). Yet, PrCS discussions remain complex, challenging and often emotional for physicians and average-risk men.ObjectiveIn July 2011, the Centers for Disease Control and Prevention convened a multidisciplinary expert panel to identify priorities for funding agencies and development groups to promote evidence-based, value-concordant decisions between men at average risk for prostate cancer and their physicians.DesignTwo-day multidisciplinary expert panel in Atlanta, Georgia, with structured discussions and formal consensus processes.ParticipantsSixteen panelists represented diverse specialties (primary care, medical oncology, urology), disciplines (sociology, communication, medical education, clinical epidemiology) and market sectors (patient advocacy groups, Federal funding agencies, guideline-development organizations).Main measuresPanelists used guiding interactional and evaluation models to identify and rate strategies that might improve PrCS discussions and decisions for physicians, patients and health systems/society. Efficacy was defined as the likelihood of each strategy to impact outcomes. Effort was defined as the relative amount of effort to develop, implement and sustain the strategy. Each strategy was rated (1-7 scale; 7 = maximum) using group process software (ThinkTank(TM)). For each group, intervention strategies were grouped as financial/regulatory, educational, communication or attitudinal levers. For each strategy, barriers were identified.Key resultsHighly ranked strategies to improve value-concordant shared decision-making (SDM) included: changing outpatient clinic visit reimbursement to reward SDM; development of evidence-based, technology-assisted, point-of-service tools for physicians and patients; reframing confusing prostate cancer screening messages; providing pre-visit decision support interventions; utilizing electronic health records to promote benchmarking/best practices; providing additional training for physicians around value-concordant decision-making; and using re-accreditation to promote training.ConclusionsConference outcomes present an expert consensus of strategies likely to improve value-concordant prostate cancer screening decisions. In addition, the methodology used to obtain agreement provides a model of successful collaboration around this and future controversial cancer screening issues, which may be of interest to funding agencies, educators and policy makers.

Dataset Information

Communication regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy".

Publications

Communication regarding the article "An efficient primary screening COVID-19 by serum Raman spectroscopy".

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets